Philips DreamStation receives medically necessary designation for certain patients
By HME News Staff
Updated 10:50 AM CDT, Thu March 19, 2026
ANDOVER, Mass. – Philips has announced that DreamStation BiPAP AVAPS devices have been designated as medical necessary for lower-weight patients with breathing impairment. The devices, which include S, T, S/T, and PC modes with AVAPS, are available for sale in the United States for new setups for patients with obstructive sleep apnea (OSA) and respiratory impairment, who are both >7 years of age and weighing 40-66 pounds. “Patient safety is at the heart of everything we do, and expanding access to advanced, reliable care is essential,” said Sam Talya, business category leader, Therapy Platforms, Sleep and Respiratory Care at Philips. “The availability of DreamStation BiPAP AVAPS devices in the US for lower-weight patients supports a limited patient population. It is a signal of our commitment to ensure access to safe, effective respiratory solutions for patients who need them most.” Philips says it is also committed to returning to serving all patients when it has fully met the requirements of the Philips Respironics consent decree, a separate set of legal requirements that the company is diligently working to meet.
Comments